REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
09/03/2021 12:50
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210309:nBw7qb7m3a&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 08 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,795,167 1.39% 182,081 0.14%
(2) Derivatives (other than options):
103,127 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,904,394 1.48% 195,247 0.15%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 225.2000 USD
Purchase 1 225.3000 USD
Purchase 1 225.4900 USD
Purchase 2 228.3000 USD
Purchase 3 225.8500 USD
Purchase 4 225.6400 USD
Purchase 4 225.7300 USD
Purchase 8 226.0300 USD
Purchase 9 227.6966 USD
Purchase 90 228.1100 USD
Purchase 99 225.4100 USD
Purchase 100 228.3200 USD
Purchase 100 228.6600 USD
Purchase 120 225.2200 USD
Purchase 188 229.0112 USD
Purchase 200 228.7920 USD
Purchase 300 226.4766 USD
Purchase 872 229.4060 USD
Purchase 1,077 228.6205 USD
Purchase 1,642 227.4367 USD
Purchase 1,702 227.3585 USD
Purchase 2,197 227.0776 USD
Purchase 2,577 225.4046 USD
Purchase 2,928 225.2310 USD
Purchase 4,622 225.2300 USD
Purchase 13,278 226.7660 USD
Sale 2 228.8800 USD
Sale 8 226.0300 USD
Sale 28 229.9500 USD
Sale 42 228.2400 USD
Sale 100 230.0800 USD
Sale 100 229.6300 USD
Sale 100 228.9700 USD
Sale 108 226.0462 USD
Sale 148 227.9164 USD
Sale 180 225.2200 USD
Sale 200 226.6280 USD
Sale 245 225.2355 USD
Sale 264 228.3561 USD
Sale 382 228.0600 USD
Sale 410 228.9938 USD
Sale 872 229.4060 USD
Sale 1,115 227.5608 USD
Sale 1,260 227.2477 USD
Sale 1,331 228.2548 USD
Sale 1,332 225.2322 USD
Sale 1,396 227.2163 USD
Sale 2,248 225.2299 USD
Sale 2,366 228.1324 USD
Sale 2,575 225.4019 USD
Sale 2,765 227.7197 USD
Sale 3,197 227.0478 USD
Sale 4,253 225.2300 USD
Sale 12,246 226.6263 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 9 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210309005597/en/
(https://www.businesswire.com/news/home/20210309005597/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
Announcement